(Q28193807)

English

Rhabdomyolysis with concurrent atorvastatin and diltiazem

scientific article (publication date: October 2002)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Rhabdomyolysis with concurrent atorvastatin and diltiazem (English)

0 references

1 reference

John J Lewin

1

0 references

Jean M Nappi

series ordinal

2

0 references

Marian H Taylor

series ordinal

3

0 references

language of work or name

English

0 references

publication date

October 2002

0 references

published in

Annals of Pharmacotherapy

0 references

volume

36

0 references

issue

10

0 references

page(s)

1546-9

0 references

cites work

Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors: the role of metabolism-monograph for physicians

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1A481

retrieved

21 January 2018

Rhabdomyolysis and HMG-CoA reductase inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1A481

retrieved

21 January 2018

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1A481

retrieved

21 January 2018

Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1A481

retrieved

21 January 2018

Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1A481

retrieved

21 January 2018

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1A481

retrieved

21 January 2018

Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1A481

retrieved

21 January 2018

A method for estimating the probability of adverse drug reactions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1A481

retrieved

21 January 2018

Defining patient risks from expanded preventive therapies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1A481

retrieved

21 January 2018

Identifiers

DOI

10.1345/APH.1A481

0 references

PubMed publication ID

12243603

0 references

(Q28193807)

Rhabdomyolysis with concurrent atorvastatin and diltiazem

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)